Revvity, Inc. (RVTY)
NYSE: RVTY · Real-Time Price · USD
99.30
+0.35 (0.35%)
At close: May 12, 2026, 4:00 PM EDT
97.45
-1.85 (-1.86%)
After-hours: May 12, 2026, 7:21 PM EDT
Revvity Revenue
Revvity had revenue of $711.12M in the quarter ending April 5, 2026, with 6.97% growth. This brings the company's revenue in the last twelve months to $2.90B, up 4.79% year-over-year. In the year 2025, Revvity had annual revenue of $2.86B with 3.67% growth.
Revenue (ttm)
$2.90B
Revenue Growth
+4.79%
P/S Ratio
3.83
Revenue / Employee
$263,855
Employees
11,000
Market Cap
11.10B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 28, 2025 | 2.86B | 101.02M | 3.67% |
| Dec 29, 2024 | 2.76B | 4.46M | 0.16% |
| Dec 31, 2023 | 2.75B | -561.25M | -16.95% |
| Jan 1, 2023 | 3.31B | -515.99M | -13.48% |
| Jan 2, 2022 | 3.83B | 1.16B | 43.73% |
| Jan 3, 2021 | 2.66B | -220.44M | -7.64% |
| Dec 29, 2019 | 2.88B | 105.67M | 3.80% |
| Dec 31, 2018 | 2.78B | 521.02M | 23.08% |
| Dec 31, 2017 | 2.26B | 141.46M | 6.69% |
| Jan 1, 2017 | 2.12B | 10.70M | 0.51% |
| Jan 3, 2016 | 2.10B | 34.94M | 1.69% |
| Dec 28, 2014 | 2.07B | -87.71M | -4.07% |
| Dec 29, 2013 | 2.16B | 52.40M | 2.49% |
| Dec 30, 2012 | 2.11B | 186.68M | 9.73% |
| Jan 1, 2012 | 1.92B | 216.74M | 12.74% |
| Jan 2, 2011 | 1.70B | 151.00M | 9.74% |
| Jan 3, 2010 | 1.55B | -108.90M | -6.56% |
| Dec 28, 2008 | 1.66B | -69.21M | -4.00% |
| Dec 30, 2007 | 1.73B | 251.19M | 17.00% |
| Dec 31, 2006 | 1.48B | 3.86M | 0.26% |
| Jan 1, 2006 | 1.47B | 44.74M | 3.13% |
| Jan 2, 2005 | 1.43B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Labcorp Holdings | 14.14B |
| Quest Diagnostics | 11.28B |
| ICON Public Limited Company | 8.10B |
| Illumina | 4.39B |
| Mettler-Toledo International | 4.09B |
| Charles River Laboratories International | 4.03B |
| Medpace Holdings | 2.68B |
| Natera | 2.50B |
RVTY News
- 5 days ago - Revvity price target raised to $105 from $95 at Barclays - TheFly
- 5 days ago - Revvity price target lowered to $117 from $125 at Baird - TheFly
- 5 days ago - Revvity price target lowered to $100 from $110 at Stifel - TheFly
- 5 days ago - Revvity price target lowered to $90 from $96 at JPMorgan - TheFly
- 5 days ago - Revvity price target raised to $120 from $115 at TD Cowen - TheFly
- 7 days ago - Revvity Earnings Call Transcript: Q1 2026 - Transcripts
- 7 days ago - Revvity reports Q1 adjusted EPS $1.06, consensus $1.02 - TheFly
- 7 days ago - Revvity sees FY26 adjusted EPS $5.20-$5.30, consensus $5.40 - TheFly